- About Us
- Our Solutions
- Jobs and People
- Contact Us
Paul Meister, Chairman and Chief Executive Officer, inVentiv Health
Paul Meister, Chairman and Chief Executive Officer of inVentiv Health, brings more than 25 years
of operating and financial management experience to his role at the company. He also is co-founder of Liberty Lane Partners, LLC, part of a private investment group that acquired inVentiv Health in August 2010.
Mr. Meister previously served as Chairman of the Board of Thermo Fisher Scientific Inc. and Vice Chairman of Fisher Scientific International Inc. During his tenure as an executive officer of Fisher Scientific from 1991 to 2006, the company's revenue grew at a compound annual rate of 15 percent, and operating income grew 23 percent, as operations expanded from two countries to 27 and sales expanded into 140 countries worldwide. Fisher Scientific International provides services and products to pharmaceutical and biotech companies, medical research institutions, and the scientific community.
From 1986 to 1995, Mr. Meister held executive positions with the Henley Group, Wheelabrator Technologies and Abex, Inc.
Mr. Meister holds a Bachelor of Arts degree from the University of Michigan and an MBA from Northwestern University. He is a director of LKQ Corporation, Scientific Games Corporation, co-chair of the University of Michigan’s Life Sciences Institute External Advisory Board and serves on the Executive Advisory Board of the Chemistry of Life Processes Institute at Northwestern University.
Mike Bell, Chief Operating Officer
Mike Bell brings valuable experience to this position, gained over a varied and distinguished career that includes three decades managing people-oriented businesses. He has held leadership roles in small start up's and rapid-growth environments, as well as executive operating roles in large, global organizations.
While serving as Senior Executive Vice President of John Hancock Financial Services, reporting to the Chairman and CEO, Mr. Bell almost doubled the growth rate of the businesses he managed while improving margins and raising productivity to some of the highest levels in the industry. Prior to this, Mr. Bell co-founded and helped lead the Monitor Group, which worked with companies across the healthcare delivery system. Monitor Group grew rapidly to 1,000 employees and opened 25 offices around the world. He also has served as a Managing Partner and founder of Monitor Clipper Partners, a private equity firm, where his industry specialties included professional services, procurement outsourcing and pharmaceutical marketing services.
Mr. Bell received his Bachelor's from The Wharton School at the University of Pennsylvania before attending Harvard Business School for an M.B.A. He serves as the Chairman Emeritus of Brigham and Women's Hospital, and previously served as a trustee and the Chair of Brigham and Women's/Faulkner Hospitals. Mr. Bell also shares his business skills and knowledge as an Adjunct Lecturer at Babson College, and holds several other leadership positions with not-for-profit organizations.
Eric Sherbet, General Counsel, inVentiv Health
Eric M. Sherbet is General Counsel of inVentiv Health. Prior to joining inVentiv Health, Mr. Sherbet served as Vice President, Deputy General Counsel, and Corporate Secretary of Foster Wheeler, AG, a $5 billion global engineering, construction, and power company. Sherbet has also held positions with Avaya, Inc.; Paul, Hastings, Janofsky & Walker LLP; and KPMG Peat Marwick.
Mr. Sherbet is a member of the New York State Bar Association and serves on its Committee on Securities Regulation.
He is also President of the New York chapter of the Corporate Secretaries and Governance Professionals and is a member of the National Board of Directors, Society of Corporate Secretaries and Governance Professionals.
Mr. Sherbet graduated from the University of Virginia with a concentration in accounting and holds a law degree from the New York University School of Law.
Sydney Rubin, Chief Communications Officer, inVentiv Health
Sydney Rubin, Chief Communications Officer, inVentiv Health Communications, is one of the healthcare industry’s most experienced communications consultants. She has more than three decades of experience in corporate reputation and branding, internal communications, public relations, public affairs and journalism.
Ms. Rubin has managed public relations programs for a broad range of corporate and institutional clients in the pharmaceutical and healthcare, consumer products, technology and financial services sectors. She has developed and implemented global communications strategies for both early-stage businesses and some of the best known brands in the world, including many Fortune 100 companies.
Prior to joining inVentiv Health’s executive leadership team, Ms. Rubin served on the leadership team at Chandler Chicco Companies, where she specialized in crisis communications, content development, executive training and strategic counsel for C-Suite executives. She joined Chandler Chicco with the purchase in 2005 of the Washington, D.C. public relations and public affairs firm she founded, Ignition Strategic Communications.
Prior to Ignition, Ms. Rubin spent nearly a decade as a foreign correspondent with The Associated Press based in Paris and London and before that worked as a television producer in New York City. She is the winner of numerous awards for both her work in public relations and journalism, including an Overseas Press Club Award, Silver Anvil, Gold Quill and many others.
Ms. Rubin holds a BS in Communications from the University of Texas/Austin and a master’s degree from Columbia University.
Andrew Suchoff, Chief Human Resources Officer, inVentiv Health
Andrew Suchoff is the Chief Human Resources Officer for inVentiv Health. He brings extensive experience working across multiple industries, including life sciences. Over the course of his career, he has worked at multinational companies such as Gillette and EMD Serono, a division of Merck KGa. He brings a global perspective to the role of HR and deep skills and proven experience in building high performing, value-driven organizations. He has held global HR roles for companies with more than 30,000 employees, operating in more than 20 countries. Over his 25-year career, he has lived and worked in Asia, Switzerland and the United Kingdom. His experience in building HR infrastructure and overseeing dramatic cultural transformations as well as creating learning and development organizations has been recognized for excellence by publications such as Training Magazine.
Suchoff graduated from Northeastern University with a Bachelor of Science degree. Suchoff is a past Board member and provides counsel as asked upon to Operation A.B.L.E., a Massachusetts nonprofit organization providing support services to mature workers re-entering the work force.
Jeffrey P. McMullen, Vice Chairman, inVentiv Health, and Chairman of inVentiv Health Clinical
Mr. McMullen has more than fourty years of experience in the drug development industry in the United States, Europe, South America and Asia. After nine years with a large pharmaceutical company (now part of Sanofi) where he held positions in clinical, regulatory, and drug metabolism areas, Mr. McMullen joined a small CRO of fifteen people. He helped grow that company to become an international full service operation which was sold to Corning in 1989 and became the foundation of the Covance clinical development business. In 1996, he co-founded PharmaNet where he was President and CEO until joining the board of inVentiv as vice chair.
Michael A. Griffith, Executive Vice President, inVentiv Health
Michael A. Griffith leads inVentiv’s Commercial and Consulting businesses. He combines deep financial expertise with extensive knowledge of pharmaceutical sector drawn from his leadership of several successful biotech and pharmaceutical companies over nearly two decades.
Most recently, Mr. Griffith was the Chief Executive Officer of Laureate Biopharma, a contract manufacturing organization providing outsourced biologics development and manufacturing services to the biopharmaceutical industry. Mr. Griffith also founded and served as Chief Executive Officer of Aptuit, with the mission of creating and engineering a better drug development process. He also served as Chairman and CEO of ChiRex, the foremost pharmaceutical process development company of its time.
Mr. Griffith started his career in the financial services sector, working at both Bankers Trust Company and Credit Suisse First Boston. Additionally, he’s served on numerous Boards including Repligen Corporation and Centrue Financial Corporation. Mr. Griffith holds a Master of Management from the Kellogg Graduate School of Management at Northwestern University and received his B.S. degree from the University of Kansas.
Joseph Solfaro, Chief Information Officer, inVentiv Health
Joe Solfaro, Chief Information Officer of inVentiv Health, has more than 25 years of technology leadership experience. Mr. Solfaro joined inVentiv Health to spearhead overarching transformative change that will fully integrate and streamline the company’s various global lines of business into an even more cohesive, interconnected enterprise. He partners with other members of the executive management team to develop and deploy strategic plans that optimize IT in support of the company’s long-term objectives and vision.
Prior to joining inVentiv Health, Mr. Solfaro was Executive Director of IT Shared Services at Merck & Co., Inc., a leading research-driven healthcare company. At Merck, he served as global steward for all Information Management capabilities at the enterprise level. He focused on service to all lines of business, including Collaboration and Content Management, Global Data Services (Data Quality, Business Intelligence, Database Management), Business Process Management, Integration, Testing and Software Quality Assurance, general application development and support. Mr. Solfaro also oversaw investments in technology strategy, portfolio, development, implementation and support for Merck's Clinical, Biostatistics and Data Management/Operations units globally, as well as R&D shared application service assets.
Mr. Solfaro received a MS degree in Engineering (System) Management from Capitol College in 1996, and a BS in Computer Science from St. Peter’s College in 1986. He is the founder and remains on the Board of ClearEdge Consulting.
Mark Dmytruk, President, inVentiv Health Patient Outcomes
Mark Dmytruk is President of inVentiv Health Patient Outcomes, a sub-segment of the inVentiv Health Commercial segment. He is based at inVentiv Health’s headquarters in Burlington, Massachusetts.
inVentiv Health Patient Outcomes provides a broad range of services relating to patient adherence, patient reimbursement and financial assistance, disease management and cost containment, accountable care solutions, and risk management consulting. inVentiv companies operating under this sub-segment include Adheris, inVentiv Patient Access Solutions and ParagonRx.
Mr. Dmytruk has extensive experience in the healthcare, life sciences, and diagnostics industries, including emerging and international market development. He joined inVentiv Health from Athena Diagnostics, a leader in molecular diagnostics and personalized medicine, where he was Vice President of Finance and a member of the executive leadership team. Prior to Athena, Mr. Dmytruk was Vice President of Corporate Development at Thermo Fisher Scientific, where he led Thermo Fisher’s merger and acquisition activity worldwide and contributed to revenue growth from $3B to $10B over eight years. Other affiliations include working with Ernst & Young in both Canada and Eastern Europe.
Mr. Dmytruk holds a bachelor’s degree from the University of Alberta in Edmonton, Canada, and an MBA from the Sloan School of Management at MIT.
Kelly Gratz, President, inVentiv Health Commercial Solutions
Kelly Gratz’s most recent responsibilities include serving as President of inVentiv Health Selling Accelerators, championing the integration across the Commercial Division. She has a unique blend of experience, holding senior positions within inVentiv’s communications and commercial divisions, and leading collaborative initiatives across all segments of the business.
Kelly has been at the forefront of ReAgent™, a proprietary methodology to strategically allocate and optimize commercialization resources. Kelly also brings direct experience in driving topline growth for brands in an outsourced, risk sharing model as well as operational experience.
Since joining inVentiv Health in 2000, Kelly has been directly involved in driving multi-channel success for a number of pharmaceutical clients, including Ortho-McNeil Neurologics, Merck, Ethicon, TAP, BMS, Eli Lilly and Company, Genentech, AstraZeneca, GlaxoSmithKline, Ross Products, Takeda, and UCB Pharma.
Prior to inVentiv Health, Kelly served in an executive management position for Symix Systems, a marketer and developer of e-business software. Previous to Symix, Kelly spent over 10 years with Ernst & Young LLP in their management consulting group, working with Fortune 500 companies to improve processes and increase overall efficiencies throughout each organization.
Paul Mignon, President, inVentiv Health Selling Solutions
Mr. Mignon successfully leads inVentiv Health Selling Solutions, which encompasses all of the companies
that relate to sales teams and sales support services.
In his current role, Mr. Mignon is responsible for the development and execution of comprehensive, customized selling solutions that support many of the major pharmaceutical firms, as well as effectively delivering cross-selling and integrated solutions to clients that include services across the broader inVentiv Health organization.
Mr. Mignon joined inVentiv Health in 2002 when he assumed the leadership role for the sales organization. Since that time, he has expanded the active client roster and significantly diversified their service portfolio.
As a consultative business partner, Mr. Mignon has strengthened and stabilized client relationships by providing innovative products and services to meet the challenges of the dynamic pharmaceutical marketplace.
Mr. Mignon’s depth of experience is built on a successful 14-year career with Johnson & Johnson. During his tenure, he was recognized for many significant accomplishments while holding various leadership roles within the Johnson & Johnson family of companies, including National Sales Director, Sales Training Director, Product Director, and Division Manager.
Mr. Mignon is a graduate of Lafayette College, where he holds a bachelor’s degree in history. He is a member of the editorial board for Product Management Today and serves on the Board of Directors for the Cancer Institute of New Jersey.
Darius Naigamwalla, President, Campbell Alliance
As President of Campbell Alliance, Darius Naigamwalla brings extensive pharmaceutical and biotechnology industry expertise to inVentiv Health. Prior to joining Campbell Alliance, Mr. Naigamwalla was a research associate at the University of Western Ontario. He began his career at Campbell Alliance as a consultant in 2001 and has held roles of increasing responsibility since then, moving up the consulting ranks to become a Practice Leader, Managing Director and, most recently, President.
Mr. Naigamwalla holds an MBA from the University of Victoria, a master’s degree in biochemistry and molecular biology from the University of Western Ontario, and a bachelor’s degree in biochemistry from McMaster University.
Ray Hill, Executive Vice President, inVentiv Health
Ray Hill brings extensive experience in successfully growing pharmaceutical services businesses and leading productive teams to the organization. He has lived and worked in Asia, Europe, and the United States.
Prior to joining inVentiv Health in 2012, Mr. Hill was CEO at Pharmaceutical Product Development, Inc., where he successfully oversaw the process of taking the company private. Before that, he was President at IMS Consulting Group, where he led an aggressive strategy of organic growth and acquisitions – building the business to $500M in 2010, and then helping to take the company private. Prior to IMS, Mr. Hill held a series of other positions in pharmaceutical consulting. He earned a bachelor’s degree from Cornell University and a master’s degree from Duke University.